Journal of Enzyme Inhibition and Medicinal Chemistry · 2012 · 14 citations · 21 references
Life SciencesMedicinal ChemistryPharmacologyHormone BiochemistryReproductive EndocrinologySteroid BiochemistryAndrogen PhysiologyGonadal HormonesGonadal Steroid HormonesSteroid MetabolismSteroid PharmacologySteroidogenic Enzymes5 Alpha-reductase5-Alpha-reductase InhibitionAndrogen Conversion EnzymesAndrogen MetabolismAndrogen ReceptorsAromatase ActivityChemical SubstituentsReceptors
The aim of these studies was to synthesize twelve ester derivatives of dehydroepiandrosterone with therapeutic potential. The effect of 1-12 was demonstrated in the flank organs of gonadectomized hamsters treated with testosterone and the synthesized steroids. In vitro studies were carried out determining the IC50 values for the inhibition of the activity of 5α-reductase type 1 and 2, which are present in rat liver and human prostate respectively. The binding of 1-12 to the androgen receptors (AR) was determined using rat's prostate cytosol. Steroids 1-12 containing different substituents in the phenyl group of the ester moiety in C-3 reduced the flank organs and inhibited the activity of 5α-R type 1; however only steroids 1 and 2 inhibited 5α-R type 2. 1-12 did not bind to the AR. The modification of one atom of the substituents in the phenyl group of the ester moiety in C-3 changed their biological potency (IC50).
21